ACG, a leading global supplier of integrated manufacturing solutions for the pharmaceutical and nutraceutical industries, has announced the commencement of operations at its state-of-the-art capsule manufacturing facility in Rayong, Thailand.

The new facility, the largest of its kind in Thailand, is dedicated to the production of empty hard gelatin capsules and is strategically located to serve key markets across Asia.

This facility is set to play a pivotal role in ACG’s global operations, increasing the company’s capacity to meet the growing demand for high-quality capsules in the region. In addition to Thailand, countries such as Indonesia, Vietnam, South Korea, Malaysia, and the Philippines will benefit from shorter transit times and enhanced supply chain efficiencies.

The 175,000-square-meter facility will employ 250 people and is designed to produce 20 billion capsules annually. ACG also aims to secure approvals to supply capsules to China from this facility, further extending its regional reach.

Karan Singh, Managing Director of ACG, commented on the expansion, saying, “Thailand has always been a strategic market for us, and the establishment of our Rayong facility marks another important milestone in our global journey, following our successes in Latin America and North America. With over a decade of experience in Southeast Asia, we recognize the region’s significant growth potential. By establishing a local presence, we are not only enhancing our capabilities and bringing advanced technology closer to our customers but also significantly reducing delivery times to improve operational efficiency. This move underscores our commitment to strengthening our position in the Asian markets and consistently delivering high-quality value to our partners in the region.